Current Screening Recommendations for Type 2 Diabetes

Agency

Strategy

Specimen

Type of Collection

Positive Test (mmol/L)

Repeat Interval

WHO

Selective, target risk factors

Urine, blood (plasma)

Fasting, random

≥6.5, ≥7.0-8.0

NS

BDA

Selective, target risk factors

Urine, blood (plasma)

2-h postprandial, fasting

≥trace, ≥6.7

5 years

USPSTF

Selective, target risk factors

Blood (plasma)

2-h 75 g OGTT, fasting

≥8.0

Clinical discretion

CTFPHE

Selective, target risk factors

Urine, blood

NS, fasting random

NS

NS

ADA

Selective, using risk assessment questionnaire

Blood (plasma)

Fasting (≥8h), random (<8h), 2-h 75 g OGTT, fasting, random

≥7.0, ≥8.9, ≥11.1, ≥6.1, ≥7.8

3 years